Living well: Tackling iron deficiency in women and girls with a genetic bleeding disorder
Improving clinical practice and the quality of life of those affected will help to position THS as an effective patient advocate and strengthen trust with its supporter base. Action will satisfy corporate sponsors and encourage them to fund future projects. Supporters may be empowered to improve their own care, improving perceptions of THS’s relevance to their lives.
To identify the best strategy, THS must first understand current practice regarding the monitoring and treatment of women and girls with a genetic bleeding disorder.
An additional factor in addressing iron deficiency, as well as other HMB-related issues, is the stigma and shame some women and girls feel in discussing their periods[10]. Also, because of the genetic nature of bleeding disorders, some women do not know what a ‘normal’ period looks like because the other females in their family bleed the same way[11].
Research suggests that despite a growing recognition of women’s bleeding disorders, specialist clinicians have been slow to adapt their care.
…. your emphasis on partnership working and in addressing the stigma of heavy menstrual bleeding suggests the contribution that PR and comms can make to The Haemophilia Society. Your approach shows clear linkages between the research and the formulation of objectives, so it’s a strong response to the assignment brief……………. You understand your brief and write very precisely about the causes and effects of iron deficiency anaemia…….You make a coherent case to first address the stigma and then treat the symptoms – and in so doing you turn a clinical campaign into a comms campaign.